A retrospective nationwide register study to characterize and compare non-valvular atrial fibrillation (NVAF) patients in Norway treated with novel oral anticoagulants (NOACs) and warfarin on drug utilization patterns, discontinuation and bleeding complication rates (Beyond Study Norway)